The founder of the Medscan group, Evgeny Tugolukov, lost full control over the company
[ad_1]
Rusatom Healthcare JSC (part of theRosatom”) bought out an additional issue of shares of JSC Medscan, increasing its share in the capital of the group from 25,001% to 50%, a company representative told Vedomosti. The amount of the deal was not disclosed. According to Mikhail Burmistrov, General Director of Infoline Analytics, it could have amounted to 10 billion rubles.
Obtaining such a large block of shares will allow Rosatom to influence the activities of Medscan and determine its strategy, says Nikolai Bespalov, RNC Pharma Development Director. According to him, at the moment, the medical business is one of the most promising, so it is not surprising that “Rosatomdecided to increase its share of it. He noted that Medscan has been actively developing in recent years and increasing its presence in the medical services market.
[ad_2]
Source link
